issued
on 12 Nov 2024
Last Applicant/ Owned by
c/o F-Prime Capital
Cambridge
MA
02142
Serial Number
98347034 filed on 08th Jan 2024
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical and scientific research in the field of radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields oncology, cancer, and radiology; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy Drug delivery agents consisting of compounds that facilitate deli Read More
Medical and scientific research in the field of radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields oncology, cancer, and radiology; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy
N/A
N/A
Drug delivery agents consisting of compounds that facilitate delivery of targeted radiation therapy; pharmaceutical preparations for use in targeted radiation therapy for the treatment of cancer; pharmaceutical preparations for the treatment of cancer
N/A
N/A
No 98347034
No Service/Collective Mark
No A13892000400
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Dec 2024 | TEAS STATEMENT OF USE RECEIVED |
12th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
17th Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
17th Sep 2024 | PUBLISHED FOR OPPOSITION |
28th Aug 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
14th Aug 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
14th Aug 2024 | EXAMINER'S AMENDMENT ENTERED |
14th Aug 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
14th Aug 2024 | EXAMINERS AMENDMENT -WRITTEN |
14th Aug 2024 | EXAMINERS AMENDMENT E-MAILED |